Atlas Legacy Advisors LLC Lowers Holdings in Procter & Gamble Company (The) $PG

Atlas Legacy Advisors LLC reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 14.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,287 shares of the company’s stock after selling 560 shares during the period. Atlas Legacy Advisors LLC’s holdings in Procter & Gamble were worth $524,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC purchased a new position in Procter & Gamble in the first quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its position in shares of Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after acquiring an additional 1,674,139 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 4,252 shares of the firm’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the transaction, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at approximately $8,219,202.16. This trade represents a 7.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 150,488 shares of company stock worth $23,529,718 over the last three months. 0.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on PG shares. Barclays lowered their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. UBS Group lowered their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Wells Fargo & Company dropped their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Raymond James Financial decreased their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Finally, JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $163.00 to $165.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $171.53.

Procter & Gamble Trading Up 0.2%

Shares of NYSE:PG opened at $146.06 on Friday. The stock’s 50-day simple moving average is $153.13 and its two-hundred day simple moving average is $157.29. The stock has a market capitalization of $341.30 billion, a price-to-earnings ratio of 21.32, a PEG ratio of 3.87 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $144.46 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s payout ratio is presently 61.61%.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.